vs
Montauk Renewables, Inc.（MNTK）与REGENXBIO Inc.（RGNX）财务数据对比。点击上方公司名可切换其他公司
Montauk Renewables, Inc.的季度营收约是REGENXBIO Inc.的1.4倍（$43.4M vs $30.3M），Montauk Renewables, Inc.净利率更高（5.7% vs -221.3%，领先227.1%），Montauk Renewables, Inc.同比增速更快（56.7% vs 43.0%），Montauk Renewables, Inc.自由现金流更多（$-41.1M vs $-52.8M），过去两年REGENXBIO Inc.的营收复合增速更高（39.4% vs 5.8%）
Montauk Renewables是一家总部位于美国的可再生能源企业，专注于捕获垃圾填埋场、农业废弃物产生的生物甲烷，将其转化为可再生天然气与低碳电力，为北美地区公用事业、工商业客户提供脱碳解决方案，助力能源低碳转型。
REGENXBIO Inc.是一家临床阶段生物技术企业，专注于开发针对罕见及严重遗传疾病的突破性基因疗法。公司拥有专有的腺相关病毒载体技术，既向全球生物制药合作伙伴提供技术授权，也自主推进多疾病领域的基因疗法管线研发。
MNTK vs RGNX — 直观对比
营收规模更大
MNTK
是对方的1.4倍
$30.3M
营收增速更快
MNTK
高出13.7%
43.0%
净利率更高
MNTK
高出227.1%
-221.3%
自由现金流更多
MNTK
多$11.7M
$-52.8M
两年增速更快
RGNX
近两年复合增速
5.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $43.4M | $30.3M |
| 净利润 | $2.5M | $-67.1M |
| 毛利率 | — | — |
| 营业利润率 | -3.8% | -190.0% |
| 净利率 | 5.7% | -221.3% |
| 营收同比 | 56.7% | 43.0% |
| 净利润同比 | 129.5% | -31.2% |
| 每股收益（稀释后） | $0.01 | $-1.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNTKRGNX
| Q4 25 | $43.4M | $30.3M | ||
| Q3 25 | $45.3M | $29.7M | ||
| Q2 25 | $45.1M | $21.4M | ||
| Q1 25 | $42.6M | $89.0M | ||
| Q4 24 | $27.7M | $21.2M | ||
| Q3 24 | $65.9M | $24.2M | ||
| Q2 24 | $43.3M | $22.3M | ||
| Q1 24 | $38.8M | $15.6M |
净利润MNTKRGNX
| Q4 25 | $2.5M | $-67.1M | ||
| Q3 25 | $5.2M | $-61.9M | ||
| Q2 25 | $-5.5M | $-70.9M | ||
| Q1 25 | $-464.0K | $6.1M | ||
| Q4 24 | $-8.5M | $-51.2M | ||
| Q3 24 | $17.0M | $-59.6M | ||
| Q2 24 | $-712.0K | $-53.0M | ||
| Q1 24 | $1.9M | $-63.3M |
毛利率MNTKRGNX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 70.2% | ||
| Q3 24 | 43.8% | 48.8% | ||
| Q2 24 | 15.6% | 52.5% | ||
| Q1 24 | 22.8% | 72.6% |
营业利润率MNTKRGNX
| Q4 25 | -3.8% | -190.0% | ||
| Q3 25 | 9.8% | -176.3% | ||
| Q2 25 | -5.2% | -296.3% | ||
| Q1 25 | 1.0% | 13.6% | ||
| Q4 24 | -35.5% | -242.1% | ||
| Q3 24 | 34.4% | -256.6% | ||
| Q2 24 | 2.0% | -251.3% | ||
| Q1 24 | 6.1% | -408.8% |
净利率MNTKRGNX
| Q4 25 | 5.7% | -221.3% | ||
| Q3 25 | 11.5% | -208.3% | ||
| Q2 25 | -12.2% | -331.8% | ||
| Q1 25 | -1.1% | 6.8% | ||
| Q4 24 | -30.5% | -241.3% | ||
| Q3 24 | 25.9% | -246.3% | ||
| Q2 24 | -1.6% | -237.7% | ||
| Q1 24 | 4.8% | -405.4% |
每股收益（稀释后）MNTKRGNX
| Q4 25 | $0.01 | $-1.30 | ||
| Q3 25 | $0.04 | $-1.20 | ||
| Q2 25 | $-0.04 | $-1.38 | ||
| Q1 25 | $0.00 | $0.12 | ||
| Q4 24 | $-0.05 | $-0.99 | ||
| Q3 24 | $0.12 | $-1.17 | ||
| Q2 24 | $-0.01 | $-1.05 | ||
| Q1 24 | $0.01 | $-1.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.8M | $230.1M |
| 总债务越低越好 | $126.0M | — |
| 股东权益账面价值 | $263.1M | $102.7M |
| 总资产 | $435.5M | $453.0M |
| 负债/权益比越低杠杆越低 | 0.48× | — |
8季度趋势，按日历期对齐
现金及短期投资MNTKRGNX
| Q4 25 | $23.8M | $230.1M | ||
| Q3 25 | $6.8M | $274.2M | ||
| Q2 25 | $29.1M | $323.3M | ||
| Q1 25 | $40.1M | $267.9M | ||
| Q4 24 | $45.6M | $234.7M | ||
| Q3 24 | $55.0M | $255.5M | ||
| Q2 24 | $42.3M | $290.4M | ||
| Q1 24 | $63.3M | $338.7M |
总债务MNTKRGNX
| Q4 25 | $126.0M | — | ||
| Q3 25 | $54.9M | — | ||
| Q2 25 | $57.8M | — | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | $43.8M | — | ||
| Q3 24 | $46.7M | — | ||
| Q2 24 | $49.7M | — | ||
| Q1 24 | $52.7M | — |
股东权益MNTKRGNX
| Q4 25 | $263.1M | $102.7M | ||
| Q3 25 | $260.7M | $161.5M | ||
| Q2 25 | $254.7M | $213.7M | ||
| Q1 25 | $258.2M | $274.2M | ||
| Q4 24 | $257.4M | $259.7M | ||
| Q3 24 | $275.3M | $301.4M | ||
| Q2 24 | $255.3M | $348.3M | ||
| Q1 24 | $254.3M | $390.7M |
总资产MNTKRGNX
| Q4 25 | $435.5M | $453.0M | ||
| Q3 25 | $383.3M | $525.2M | ||
| Q2 25 | $382.5M | $581.0M | ||
| Q1 25 | $354.2M | $490.9M | ||
| Q4 24 | $349.0M | $466.0M | ||
| Q3 24 | $374.1M | $519.1M | ||
| Q2 24 | $362.0M | $569.4M | ||
| Q1 24 | $354.7M | $629.2M |
负债/权益比MNTKRGNX
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.21× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.17× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $337.0K | $-52.3M |
| 自由现金流经营现金流 - 资本支出 | $-41.1M | $-52.8M |
| 自由现金流率自由现金流/营收 | -94.7% | -174.0% |
| 资本支出强度资本支出/营收 | 95.5% | 1.7% |
| 现金转化率经营现金流/净利润 | 0.14× | — |
| 过去12个月自由现金流最近4个季度 | $-86.2M | $-126.4M |
8季度趋势，按日历期对齐
经营现金流MNTKRGNX
| Q4 25 | $337.0K | $-52.3M | ||
| Q3 25 | $12.7M | $-56.0M | ||
| Q2 25 | $8.2M | $-49.3M | ||
| Q1 25 | $9.1M | $33.6M | ||
| Q4 24 | $724.0K | $-31.6M | ||
| Q3 24 | $28.6M | $-40.5M | ||
| Q2 24 | $193.0K | $-45.5M | ||
| Q1 24 | $14.3M | $-55.5M |
自由现金流MNTKRGNX
| Q4 25 | $-41.1M | $-52.8M | ||
| Q3 25 | $-17.2M | $-56.5M | ||
| Q2 25 | $-25.5M | $-49.7M | ||
| Q1 25 | $-2.5M | $32.6M | ||
| Q4 24 | $-8.3M | $-32.7M | ||
| Q3 24 | $16.0M | $-40.9M | ||
| Q2 24 | $-18.6M | $-46.0M | ||
| Q1 24 | $-7.7M | $-56.0M |
自由现金流率MNTKRGNX
| Q4 25 | -94.7% | -174.0% | ||
| Q3 25 | -37.9% | -189.9% | ||
| Q2 25 | -56.4% | -232.8% | ||
| Q1 25 | -5.8% | 36.6% | ||
| Q4 24 | -29.8% | -154.2% | ||
| Q3 24 | 24.3% | -168.9% | ||
| Q2 24 | -42.9% | -206.2% | ||
| Q1 24 | -19.8% | -358.5% |
资本支出强度MNTKRGNX
| Q4 25 | 95.5% | 1.7% | ||
| Q3 25 | 65.9% | 1.7% | ||
| Q2 25 | 74.6% | 1.8% | ||
| Q1 25 | 27.3% | 1.2% | ||
| Q4 24 | 32.5% | 5.1% | ||
| Q3 24 | 19.1% | 1.3% | ||
| Q2 24 | 43.3% | 2.1% | ||
| Q1 24 | 56.7% | 3.6% |
现金转化率MNTKRGNX
| Q4 25 | 0.14× | — | ||
| Q3 25 | 2.43× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.53× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.68× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 7.73× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNTK
| Natural Gas Environmental Attributes | $28.1M | 65% |
| Natural Gas Commodity | $10.7M | 25% |
| Electric Commodity | $2.7M | 6% |
| Electric Environmental Attributes | $2.0M | 5% |
RGNX
| Novartis Gene Therapies | $24.2M | 80% |
| Nippon Shinyaku Collaboration And License Agreement | $4.3M | 14% |
| Nippon Shinyaku Services | $1.4M | 5% |
